Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ensuring continuous TB treatment across Asian borders
Ist Teil von
Public health action, 2024-03, Vol.14 (1), p.20-25
Ort / Verlag
France: International Union Against Tuberculosis and Lung Disease
Erscheinungsjahr
2024
Quelle
EZB Free E-Journals
Beschreibungen/Notizen
BACKGROUND Mid-treatment cross-border migration of patients with TB increases the risk of treatment interruption. OBJECTIVE To establish a cross-border referral process for patients with TB
in Japan, and enhance their access to health facilities and treatment outcomes. DESIGN This prospective cohort study describes and assesses the process of foreign-born patients with TB who returned to their home countries during treatment,
focusing on their access to healthcare facilities and treatment outcomes. RESULTS We enrolled 135 foreign-born patients with TB, and confirmed that 112 (83.0%) were referred to and accessed healthcare facilities after returning to their home
countries. Of 102 patients due to complete treatment as of July 2023, 87 (85.3%) completed their treatment. We did not identify significant differences in the treatment success rate among patient characteristics, except between the patients with confirmed access to a healthcare facility and
those without (P < 0.001). We confirmed that 49/87 (56.3%) patients had completed treatment with official data. CONCLUSION The access and treatment success rates of the cross-bordered patients with TB from Japan were >80%; however,
we should further improve this proportion by confirming the treatment outcomes with official data.